Flamingo Pharma (UK) Ltd
Russell Williams currently serves as the Director of OTC at Flamingo Pharma (UK) Ltd since October 2023. Prior to this role, Russell held the position of Commercial Director at Oxbridge from February 2023 to August 2023. From May 2020 to December 2022, Russell was the Group Commercial Director at Dr Organic Group Ltd. Russell's experience also includes serving as the Group Sales Marketing Director at Marksans Pharma Ltd. in India from March 2014 to May 2020, and as GM & Director of International Markets at FGX International between January 2012 and March 2014. Earlier in Russell's career, management roles included Sales Director and National Account Controller at Ransom Naturals Ltd from January 2005 to December 2011.
This person is not in any teams
This person is not in any offices
Flamingo Pharma (UK) Ltd
Flamingo Pharma UK is a wholly owned subsidiary of Flamingo Pharmaceuticals India. Flamingo Pharmaceuticals India was established in 1985 and now supplies over 200 molecules to over 50 countries. Flamingo Pharmaceuticals India has been contract manufacturing high quality low cost medicines for the UK for 15 years. We have 4 manufacturing sites in India, 3 of which are MHRA approved. Flamingo Pharma UK was established in 2014 and in June 2016 began supplying the market with Flamingo Pharma UK branded GSL, P and POM medicines. We are backed by the manufacturing, development, regulatory and technical expertise of our parent company in India. Our range is growing rapidly and we would be interested in discussing UK own brand in-licensing or out-licensing into Europe. Contacts: Sales - sales@flamingopharma.co.uk To report an adverse event, or have a question, please contact safety@flamingopharma.co.uk